BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 16989163)

  • 21. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
    Schiavino D; Nucera E; Pollastrini E; De Pasquale T; Buonomo A; Bartolozzi F; Lombardo C; Roncallo C; Patriarca G
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hymenoptera venom allergy: characteristics, tolerance and efficacy of immunotherapy in the pediatric population.
    Fiandor A; Teresa Belver M
    Allergol Immunopathol (Madr); 2009; 37(3):109-10. PubMed ID: 19769841
    [No Abstract]   [Full Text] [Related]  

  • 23. Hymenoptera venom allergy.
    Ebo DG
    Verh K Acad Geneeskd Belg; 2007; 69(4):213-30. PubMed ID: 17821959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study.
    Sturm GJ; Böhm E; Trummer M; Weiglhofer I; Heinemann A; Aberer W
    Allergy; 2004 Oct; 59(10):1110-7. PubMed ID: 15355471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insect sting allergy with negative venom skin test responses.
    Golden DB; Kagey-Sobotka A; Norman PS; Hamilton RG; Lichtenstein LM
    J Allergy Clin Immunol; 2001 May; 107(5):897-901. PubMed ID: 11344359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stinging insect allergy.
    Pence HL
    Prim Care; 1979 Sep; 6(3):587-96. PubMed ID: 392579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insect Venom Immunotherapy: Analysis of the Safety and Tolerance of 3 Buildup Protocols Frequently Used in Spain.
    Gutiérrez Fernández D; Moreno-Ancillo A; Fernández Meléndez S; Domínguez-Noche C; Gálvez Ruiz P; Alfaya Arias T; Carballada González F; Alonso Llamazares A; Marques Amat L; Vega Castro A; Antolín Amérigo D; Cruz Granados S; Ruiz León B; Sánchez Morillas L; Fernández Sánchez J; Soriano Gomis V; Borja Segade J; Dalmau Duch G; Guspi Bori R; Miranda Páez A
    J Investig Allergol Clin Immunol; 2016; 26(6):366-373. PubMed ID: 27996943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability of venom skin tests.
    Goldberg A
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):342-5. PubMed ID: 17620827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venom immunotherapy in patients with allergic reactions to insect stings.
    Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
    Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mastocytosis and insect venom allergy.
    Bonadonna P; Zanotti R; Müller U
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple 3-day "rush" venom immunotherapy protocol: documentation of safety.
    Kalogeromitros D; Makris M; Koti I; Chliva C; Mellios A; Avgerinou G; Theoharides TC
    Allergol Immunopathol (Madr); 2010; 38(2):69-73. PubMed ID: 19853357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaphylaxis to insect venom.
    Mosbech H
    Novartis Found Symp; 2004; 257():177-88; discussion 188-92, 207-10, 276-85. PubMed ID: 15025398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rush hyposensitization with Hymenoptera venoms. Tolerance and results of therapy].
    Przybilla B; Ring J; Griesshammer B; Braun-Falco O
    Dtsch Med Wochenschr; 1987 Mar; 112(11):416-24. PubMed ID: 3816590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Key Issues in Hymenoptera Venom Allergy: An Update.
    Alfaya Arias T; Soriano Gómis V; Soto Mera T; Vega Castro A; Vega Gutiérrez JM; Alonso Llamazares A; Antolín Amérigo D; Carballada Gonzalez FJ; Dominguez Noche C; Gutierrez Fernandez D; Marques Amat L; Martinez Arcediano A; Martinez San Ireneo M; Moreno Ancillo A; Puente Crespo Y; Ruiz Leon B; Sánchez Morillas L;
    J Investig Allergol Clin Immunol; 2017; 27(1):19-31. PubMed ID: 28211342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy with commercial venoms is efficacious for anaphylactic reactions to Vespa orientalis stings.
    Goldberg A; Shefler I; Panasoff J; Paitan Y; Confino-Cohen R
    Int Arch Allergy Immunol; 2013; 161(2):174-80. PubMed ID: 23363701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.
    Ruëff F; Przybilla B; Biló MB; Müller U; Scheipl F; Aberer W; Birnbaum J; Bodzenta-Lukaszyk A; Bonifazi F; Bucher C; Campi P; Darsow U; Egger C; Haeberli G; Hawranek T; Kucharewicz I; Küchenhoff H; Lang R; Quercia O; Reider N; Severino M; Sticherling M; Sturm GJ; Wüthrich B;
    J Allergy Clin Immunol; 2010 Jul; 126(1):105-11.e5. PubMed ID: 20542320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnosis of hymenoptera hypersensitivity.
    Ramirez DA; Summers RJ; Evans R
    Ann Allergy; 1981 Nov; 47(5 Pt 1):303-6. PubMed ID: 7316245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Th1, Th2, lymphocyte trafficking and activation markers on CD4+ T-cells of Hymenoptera allergic subjects and after venom immunotherapy.
    Cabrera CM; Urra JM; Alfaya T; Roca Fde L; Feo-Brito F
    Mol Immunol; 2014 Nov; 62(1):178-85. PubMed ID: 25004111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hymenoptera hypersensitivity in an imported fire ant endemic area.
    Freeman TM
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):369-72. PubMed ID: 9109704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An epidemiological survey of hymenoptera venom allergy in the Spanish paediatric population.
    Martínez-Cañavate A; Tabar AI; Eseverri JL; Martín F; Pedemonte-Marco C
    Allergol Immunopathol (Madr); 2010; 38(5):259-62. PubMed ID: 20580150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.